Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Modified Banxia Xiexin Decoction Ameliorates Polycystic Ovarian Syndrome With Insulin Resistance by Regulating Intestinal Microbiota

10 May 2022

Abstract excerpt

Objective To analyze the characteristics of the intestinal microbiota of polycystic ovarian syndrome with insulin resistance (PCOS-IR) and explore the possible mechanism of modified Banxia Xiexin Decoction in the treatment of PCOS-IR. Methods A total of 17 specific pathogen-free (SPF) female Sprague–Dawley (SD) rats, aged 21 days, were selected and randomly divided into the control group (group Z, n = 6), model...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gut microbiota and health
Share to Lipid metabolism and disorders
Share to Ovarian function and disorders

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35619648
DOI: 10.3389/fcimb.2022.854796

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Modified Banxia Xiexin Decoction Ameliorates Polycystic Ovarian Syndrome With Insulin Resistance by Regulating Intestinal MicrobiotaPMID 35619648Read ↗

Comprehensive Analysis of Gut Microbiota Alteration in the Patients and Animal Models with Polycystic Ovary SyndromeSemantic proximity Read ↗

High-Fiber Diet or Combined With Acarbose Alleviates Heterogeneous Phenotypes of Polycystic Ovary Syndrome by Regulating Gut Microbiota.Semantic proximity Read ↗

Modified Guishen Pill Ameliorates Polycystic Ovary Syndrome in Rats Through Anti-inflammation and Modulating Gut MicrobiotaSemantic proximity Read ↗

Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applicationsSemantic proximity Read ↗

Polycystic Ovary Syndrome: Etiology, Current Management, and Future TherapeuticsSemantic proximity Read ↗

Xiexin Tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiotaSemantic proximity Read ↗

Probiotic Bifidobacterium lactis V9 regulates the intestinal microbiome in patients with polycystic ovary syndromeSemantic proximity Read ↗

Alteration of gut microbiota in polycystic ovary syndrome patients and the correlated clinical parameters: a cross-sectional analysis study from Chinese womenSemantic proximity Read ↗

16S rDNA Full-Length Assembly Sequencing Technology Analysis of Intestinal Microbiome in Polycystic Ovary SyndromeSemantic proximity Read ↗

Dysbiotic alteration in the fecal microbiota of patients with polycystic ovary syndromeSemantic proximity Read ↗

Traditional Chinese Medicine Formula Kang Shuai Lao Pian Improves Obesity, Gut Dysbiosis, and Fecal Metabolic Disorders in High-Fat Diet-Fed MiceSemantic proximity Read ↗

Gut Microbiota of Chinese Obese Children and Adolescents With and Without Insulin ResistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.